Armata Pharmaceuticals (ARMP) Receivables - Other (2022 - 2026)
Quarterly results put Receivables - Other at $100000.0 for Q1 2026, down 50.0% from a year ago — trailing twelve months through Mar 2026 was $100000.0 (down 50.0% YoY), and the annual figure for FY2025 was $500000.0, down 32.8%.
Armata Pharmaceuticals has reported Receivables - Other over the past 5 years, most recently at $100000.0 for Q1 2026.
- Receivables - Other reached $100000.0 in Q1 2026 per ARMP's latest filing, down from $500000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $7.4 million in Q2 2023 and bottomed at $100000.0 in Q1 2026.
- Median Receivables - Other over the past 5 years was $1.5 million (2023), compared with a mean of $2.5 million.
- The largest annual shift saw Receivables - Other crashed 89.86% in 2024 before it skyrocketed 194.12% in 2025.
- Over 5 years, Receivables - Other stood at $6.6 million in 2022, then crashed by 77.26% to $1.5 million in 2023, then tumbled by 53.33% to $700000.0 in 2024, then decreased by 28.57% to $500000.0 in 2025, then tumbled by 80.0% to $100000.0 in 2026.
- Business Quant data shows Receivables - Other for ARMP at $100000.0 in Q1 2026, $500000.0 in Q4 2025, and $2.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Jun 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 748,000.00 |
| Jun 30, 2024 | 748,000.00 |
| Mar 31, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 7.27 Mn |
| Sep 30, 2023 | 7.27 Mn |
| Jun 30, 2023 | 7.38 Mn |
| Jun 30, 2023 | 7.38 Mn |
| Dec 31, 2022 | 6.60 Mn |
| Dec 31, 2022 | 6.60 Mn |